Pathophysiologic Targets

4 min · 5. mar. 2024

Description

Diabetes Pathophysiology Glucagon-Like Peptide-1 Mechanisms

Be the first to comment

Sign up now and become a member of the Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists community!

7 episodes

Cardiologist Collaboration

Role in Diabetes Management Multidisciplinary Team-based Approach

Individualizing Therapy

Drug Initiation and Monitoring Contraindications and Adverse Effects Patient Education

Cardiovascular Benefits

* FDA Indications * Clinical Trial Evidence

Glycemic/Non-Glycemic Effects

Short-Acting versus Long-Acting Agents Fasting and Postprandial Blood Glucose Gastric Emptying and Body Weight

Pathophysiologic Targets

Diabetes Pathophysiology Glucagon-Like Peptide-1 Mechanisms